Uterine

Nicole C Kelp, Cindy A Pru, Sandeep Paudel, John P Lydon, J Julie Kim, John J Peluso, James K Pru

Abstract read

In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Neurosteroids Progesterone and Dehydroepiandrosterone: Molecular Mechanisms of Action in Neuroprotection and Neuroinflammation.Pharmaceuticals (Basel, Switzerland) · 2025
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nicole C KelpCenter for Reproductive Biology, School of Molecular Biosciences and Department of Animal Sciences, Washington State University, Pullman, WA 99163, USA.ORCID 0000-0001-8462-5689

Cindy A PruCenter for Reproductive Biology, School of Molecular Biosciences and Department of Animal Sciences, Washington State University, Pullman, WA 99163, USA.

Sandeep PaudelProgram in Reproductive Biology, Department of Animal Science, University of Wyoming, Laramie, WY 82071, USA.

John P LydonDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.

J Julie KimDivision of Reproductive Science in Medicine, Department of Obstetrics and Gynecology, Northwestern University, Chicago, IL 60611, USA.ORCID 0000-0001-9834-8213

John J PelusoDepartments of Cell Biology and Obstetrics and Gynecology, University of Connecticut Health Center, Farmington, CT 06030, USA.

James K PruCenter for Reproductive Biology, School of Molecular Biosciences and Department of Animal Sciences, Washington State University, Pullman, WA 99163, USA.

Funding

Curtis and Marian Rochelle EndowmentNIH HHS 1R01HD102386-03A1NIH HHS 1R21HD016564-02A1NIH HHS 1R21HD086402-02A1NSF GRFP1347973USDA WYO-632-22USDA WYO-657-24

6 · The paper itself

Abstract

The expression of members of the progesterone receptor membrane component (PGRMC) family, particularly PGRMC1, is elevated in diverse types of cancers, particularly those of the female reproductive system. While xenograft tumor studies using human transformed cell lines in immunocompromised mice have suggested that

Indexed as

cancerendometrialhyperplasiaPGRMC1PGRMC2progesteronePTENuterus

Identifiers

PMID40227710

DOI10.3390/cancers17071178

PMCPMC11988108

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.